Cystic fibrosis is a genetic respiratory disease causing thick mucus buildup in lungs and organs. New CFTR modulator therapies like Trikafta now treat the root cause, boosting life expectancy to over 50 years-but access remains unequal.
Cystic fibrosis is a genetic respiratory disease causing thick mucus buildup in lungs and organs. New CFTR modulator therapies like Trikafta now treat the root cause, boosting life expectancy to over 50 years-but access remains unequal.